Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.
about
Multivalent integrin-specific ligands enhance tissue healing and biomaterial integrationViral infection and human disease--insights from minimotifsMetal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential ApplicationsThe targeting behavior of folate-nanohydrogel evaluated by near infrared imaging system in tumor-bearing mouse model.Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivoT₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles.Self-assembled lipid nanomedicines for siRNA tumor targeting.RAM, an RGDS analog, exerts potent anti-melanoma effects in vitro and in vivo.A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligandsalpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemiaFolate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumorIntegrin targeted delivery of chemotherapeuticsTargeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT)More effective nanomedicines through particle designNovel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.Ultrasmall integrin-targeted silica nanoparticles modulate signaling events and cellular processes in a concentration-dependent manner.Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancerImaging key biomarkers of tumor angiogenesisCancer treatment using peptides: current therapies and future prospectsCoupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRISmall-molecule delivery by nanoparticles for anticancer therapyIntegrins in angiogenesis and lymphangiogenesisClustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.Morphological and reproductive characterization in hyacinth bean, Lablab purpureus (L.) sweet germplasm with clinically proven nutraceutical and pharmaceutical traits for use as a medicinal food.Optimising the delivery of tubulin targeting agents through antibody conjugation.Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.Virus-Derived Peptides for Clinical Applications.Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.Gold nanoparticle surface functionalization: mixed monolayer versus hetero bifunctional peg linker.In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel.Antitumor activity of recombinant RGD-IFN-α2a-core fusion protein in vitro.Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.RGDfK-functionalized gold nanorods bind only to activated platelets.Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties.Integrin-targeted paclitaxel nanoliposomes for tumor therapy.An efficient chemical approach to bispecific antibodies and antibodies of high valency
P2860
Q24599082-7B179E82-C621-477A-8DD6-3D1100A63846Q24647289-4104136D-53A5-4CEE-8318-407A511ED876Q28396375-D3B28D2B-8714-4E84-AE59-2CF52627F245Q30881372-53003F67-3B9D-471A-87E9-24545A2C7949Q33713710-0FF53A1D-42EA-4F57-B257-21A71E6328CBQ33779313-F6CE6477-1FC3-4B37-B269-A7DB739BFF4CQ33907953-A57E81F5-B375-49DF-B5E8-E82D2968E4F1Q34044872-3C79222F-3D0E-447A-BCA2-71C2E41F2BA6Q34242570-0FF9E528-CBA4-4EBE-823E-D915BC12F36CQ34357105-EC1463DF-89D7-4E04-8866-9B93EA380E9AQ34723932-E9253BAC-C514-4D36-B10B-C4611CAAFD4FQ34764419-6181F48E-DFB5-4F1D-A1C4-023B2E896633Q34912725-ECD61A9A-BB28-46EF-9E67-4C3CB79DA87FQ34927053-A47434C9-2062-4CC2-A4A7-66067A634BD4Q35106115-6A909B53-729A-4F88-AD74-4CB8EA9F2AE6Q35389145-8F14BA4A-6416-475F-B9BC-2C9D0618D224Q35562019-F5BE4710-EA9B-42E5-A185-DEDD23222F2BQ35783096-A8B78412-AA74-4428-86A5-250815C516F3Q35970627-E5DB5DBE-662B-4375-93F8-670A9CC7A51FQ35999557-257918DC-1461-4AF0-ACFC-007E2CD1D117Q36515785-D122CFD4-A614-4948-A997-F7F7199ECC84Q36915069-17A5AAF1-952A-40FB-A9C1-B3CC94DC8632Q37059874-6D399552-F79C-4F37-9B2E-965BAD2FD7A3Q37170752-78EDFB1A-D406-461A-94BD-F99432CB89FAQ37383038-C382D237-E415-4035-BFA7-34D035E6E49CQ37995663-366734E1-7AA4-4CB6-A2D6-3D673BC46B44Q38024991-7A90EB9C-FF43-4F30-9593-A558AEBEA4AAQ38364462-41D44072-8E91-4D6D-94BE-BB7482F52EFDQ38655270-5AAF89A1-12AC-4BAD-B387-B35C6889CCFAQ38729299-AD29440E-4FC2-4EC8-A59D-A509431B92D1Q38791714-5FF6F58F-AEA2-4ACD-B9B2-9266447E5526Q38865234-D44D2ED3-27F4-4ADC-AA70-3195A088C5CFQ39271628-2789F5E5-E6B1-4009-90F9-98E9EC9D0EEEQ39282791-4E7AD512-8D79-4BE6-A87E-CE32C8F4FDC3Q39322944-D7D878CE-3086-4628-A20F-FF81BEA2A502Q39371541-E7EACE5A-44E6-47C2-8674-2A6D00E132BAQ39373913-535B2A4D-20D5-4066-8E9D-1482326853F1Q39657710-30F7F40B-A76B-4370-92BA-D35D84F3861EQ39678154-E962A7D0-9FA6-467F-8956-78CA1A8466EBQ39842559-DDF8BC41-B794-4AF1-B41B-F11EF7712828
P2860
Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor targeting with RGD pepti ...... maging and therapy of cancers.
@en
type
label
Tumor targeting with RGD pepti ...... maging and therapy of cancers.
@en
prefLabel
Tumor targeting with RGD pepti ...... maging and therapy of cancers.
@en
P2093
P1476
Tumor targeting with RGD pepti ...... maging and therapy of cancers.
@en
P2093
Didier Boturyn
Elisabeth Garanger
Pascal Dumy
P304
P356
10.2174/187152007781668706
P577
2007-09-01T00:00:00Z